First human test of new oral drug formulation
NCT ID NCT04481750
Summary
This early-stage study tested the safety and how the body processes a new oral form of the drug edaravone. It involved 74 healthy adult male volunteers who took single and multiple doses. The main goals were to check for side effects and measure how much of the drug got into the bloodstream.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site
Osaka, Japan
Conditions
Explore the condition pages connected to this study.